Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Poumon, type non à petites cellules
- | Specialty :
- Immunothérapie - Vaccinothérapie
Extract
A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer